PS

Purushothaman Sowrirajan

Director DIN 03499742
DIN 03499742 First appointment Aug 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Purushothaman Sowrirajan

Data last updated:

Purushothaman Sowrirajan was a Managing Director at Indrakshi Pharma Private Limited (from 2011) and Managing Director at Sarvajitha Pharmaceuticals Private Limited (from 2011).

DIN 03499742
First Appointment 15 Aug 2011
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indrakshi Pharma Private Limited U33125TN2009PTC070372
Managing Director15 Sep 20112009Strike Off
Managing Director15 Aug 20112007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indrakshi Pharma Private Limited
Sarvajitha Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Purushothaman Sowrirajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purushothaman Sowrirajan

Purushothaman Sowrirajan was first appointed on 15 Aug 2011 as Managing Director at Sarvajitha Pharmaceuticals Private Limited.

Purushothaman Sowrirajan held 2 earlier board appointments: Indrakshi Pharma Private Limited (Managing Director, from 15 Sep 2011); Sarvajitha Pharmaceuticals Private Limited (Managing Director, from 15 Aug 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available